Access complete analytical documentation for BPC-157 reference standards. PX1 Research provides batch-specific HPLC, mass spectrometry, and endotoxin assay reports to ensure rigorous chemical identity and high purity for in vitro and preclinical laboratory investigations.
Access complete analytical documentation for BPC-157 reference standards. PX1 Research provides batch-specific HPLC, mass spectrometry, and endotoxin assay reports to ensure rigorous chemical identity and high purity for in vitro and preclinical laboratory investigations.
A certificate of analysis BPC 157 is an official quality control document issued by an accredited third-party laboratory verifying the identity, purity, chemical mass, and safety profile of a specific synthetic peptide batch. Essential for scientific reproducibility, the COA detailing BPC-157 research peptide standard confirms that the sequence exhibits greater than 99% purity and is free from residual industrial contaminants, heavy metals, or excessive bacterial endotoxins.
In rigorous experimental environments, using unverified research reagents introduces uncontrolled variables that compromise cellular assays and animal studies. PX1 Research mandates batch-specific verification for every lot manufactured in USA-based, GMP-compliant facilities. By providing public access to comprehensive peptide purity testing standards, researchers can independently confirm the analytical integrity of their active research compounds prior to benchtop application.
A comprehensive certificate of analysis BPC 157 must report several distinct physical and chemical metrics to validate compound identity. Primary among these is Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), which establishes optical purity by measuring peak area integration across an ultraviolet spectrum (typically 214 nm or 220 nm). A purity score above 98% or 99% indicates that secondary truncation sequences or side-reaction isomers are minimized to negligible trace levels.
Beyond chromatographic separation, the document must feature Electrospray Ionization Mass Spectrometry (ESI-MS) spectra. This analysis confirms the precise molecular weight of the pentadecapeptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), ensuring a monoisotopic mass that exactly matches the theoretical molecular weight of 1419.5 Da. Any variance exceeding standard instrumental tolerance limits signals sequence degradation or incomplete deprotection during solid-phase synthesis.
For cell culture studies and in vivo animal models, bacterial endotoxin content represents a critical confounder. Endotoxins, primarily lipopolysaccharides (LPS) derived from Gram-negative bacterial outer membranes, trigger inflammatory cascades in biological systems that can mask the intrinsic pharmacological action of the target compound. Every standard certificate of analysis BPC 157 supplied by PX1 Research incorporates a Limulus Amebocyte Lysate (LAL) assay to quantify endotoxin levels.
To satisfy the strict standards required for published peer-reviewed literature, testing is conducted within ISO 17025 accredited analytical facilities. Reports confirm endotoxin limits fall well below established research thresholds (typically < 0.1 EU/mg), protecting primary cell cultures and tissue explants from non-specific inflammatory signaling. Exploring our broad repository within the PX1 research library hub allows investigators to cross-reference lot numbers with historical analytical baselines.
When evaluating a certificate of analysis BPC 157, researchers must differentiate between crude peptide purity and net peptide content. While RP-HPLC reports the relative proportion of the target peptide relative to synthesized impurities, net peptide content reflects the actual weight percentage of peptide relative to bound counterions (such as trifluoroacetate or acetate) and residual moisture. Synthesized via solid-phase peptide synthesis (SPPS), raw peptide salts frequently retain trifluoroacetic acid (TFA) counterions that require lyophilizate optimization.
High-grade research preparations utilize salt exchange procedures to substitute standard TFA salts with biocompatible acetate or free-base formats when necessary. Detailed COA documentations specify net peptide mass, enabling precise molarity calculations during buffer preparation. Principal investigators sourcing through bulk lab procurement channels rely on these standardized parameters to ensure consistency across multi-phase experimental blocks.
Body Protection Compound-157 (BPC-157) is a synthetically derived 15-amino-acid peptide based on a naturally occurring gastric juice protein fragment. Preclinical studies suggest that BPC-157 accelerates the structural repair of musculoskeletal tissues, including tendons, ligaments, and skeletal muscle matrix. The primary mechanisms documented in rodent models involve the upregulation of early growth response 1 (EGR-1) gene expression and activation of the focal adhesion kinase (FAK)-paxillin pathway, promoting cell migration and extracellular matrix deposition.
Furthermore, in vitro and preclinical gut lining assays indicate that BPC-157 enhances endothelial cell capillary tube formation through vascular endothelial growth factor (VEGF) pathway modulation without accelerating uncontrolled cell proliferation. Reviewing the complete BPC-157 mechanism guide provides detailed molecular pathways observed in tissue injury and mucosal damage models.
In experimental models examining soft tissue healing and cellular repair pathways, researchers frequently evaluate BPC-157 alongside complementary biological compounds. While BPC-157 primarily targets localized cell migration, focal adhesion, and gastric mucosal integrity, other synthetic compounds operate through distinct physiological mechanisms. Understanding these differences allows laboratories to select appropriate reference standards for comparative baseline studies.
For instance, TB-500 research peptide (a synthetic fragment of Thymosin Beta-4) modulates actin filament sequestration to drive systemic cellular motility and tissue remodeling. Similarly, GHK-Cu copper peptide acts as a signal peptide involved in collagen synthesis and remodeling matrix metalloproteinases, whereas the tripeptide KPV peptide exhibits targeted anti-inflammatory signaling pathways within epithelial cell barriers. Sourcing standardized reagents across all categories via our all peptides directory guarantees consistent analytical validation.
Proper handling of lyophilizates is vital to maintaining compound integrity once analytical quality is established by the COA. Lyophilized BPC-157 trifluoroacetate or acetate salts should be stored at -20°C or -80°C in a desiccated environment to prevent moisture absorption and hydrolytic degradation. Prior to opening, vials must be allowed to equilibrate to room temperature to eliminate condensation on the inner glass surface.
Reconstitution should be performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline depending on the experimental model requirement. When preparing solution concentrations, researchers can utilize our interactive reconstitution calculator tool to determine precise molar volumes. Once dissolved, liquid aliquots should be stored at 2°C to 8°C and used within defined experimental timeframes to prevent aggregation.
PX1 Research operates dedicated manufacturing and distribution operations within the United States. Every lot of synthetic peptide undergoes standardized testing protocols before release to the scientific community. By maintaining direct control over storage conditions and processing facilities located in California and Arizona, we eliminate supply chain exposure to extreme heat and prolonged transit delays.
All domestic orders placed before standard daily cutoffs ship same-day (Monday through Friday) from our CA and AZ distribution centers. Each shipment includes direct access to lot-matched certificate of analysis BPC 157 documents, supporting strict institutional compliance and verifiable experimental protocols.
What is a certificate of analysis BPC 157?
A certificate of analysis (COA) for BPC 157 is a document provided by an independent analytical testing laboratory that details the purity, identity, molecular mass, and endotoxin levels of a specific batch of BPC-157 research peptide.
How do I verify the authenticity of a BPC 157 COA?
Authentic COAs feature lot-specific data, including raw HPLC chromatograms showing peak integration percentages, ESI-MS spectra displaying exact molecular mass, LAL endotoxin testing results, and verification numbers from accredited ISO 17025 laboratories.
What purity level should a BPC-157 research standard have?
High-grade BPC-157 research standards typically feature a purity level of 98% or higher, as determined by RP-HPLC analysis, ensuring that secondary synthesis side-products do not interfere with biological assays.
Why is endotoxin testing included on the BPC 157 certificate of analysis?
Endotoxin testing ensures that bacterial lipopolysaccharides (LPS) are below thresholds (<0.1 EU/mg) that would otherwise trigger non-specific inflammatory responses in cellular assays or animal models.
Does the COA state the net peptide content of BPC-157?
Yes, thorough COA documentation accounts for net peptide mass, distinguishing active peptide concentration from bound counterion salts (such as TFA or acetate) and residual lyophilizate moisture.
What analytical methods are used to generate a BPC 157 COA?
The primary testing methods are Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for optical purity quantification and Electrospray Ionization Mass Spectrometry (ESI-MS) for sequence mass verification.
How should reconstituted BPC-157 solutions be stored in the lab?
Reconstituted solutions should be kept under refrigeration at 2°C to 8°C for short-term use or aliquoted and frozen at -20°C to avoid multiple freeze-thaw cycles that induce peptide degradation.
Can I obtain lot-specific COAs for wholesale or bulk orders?
Yes, PX1 Research provides lot-matched third-party certificates of analysis for all standard and bulk procurement orders directly through our wholesale program.
What is the theoretical molecular mass of BPC-157 shown on the COA?
The theoretical molecular mass of the 15-amino-acid sequence BPC-157 is 1419.5 Da, which must be reflected in the mass spectrometry peak reported on the COA.
Where are PX1 Research BPC-157 compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based facilities and shipped directly from distribution locations in California and Arizona with same-day dispatch M–F.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.